| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Daniel M Couri | |
| Richard E Katholi | |||
| P2860 | cites work | Carvedilol in the treatment of hypertension--a review of the clinical data base | Q32068461 |
| Sudden death in young athletes | Q34229613 | ||
| Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial | Q34366640 | ||
| Assessment of left ventricular mass by cardiovascular magnetic resonance. | Q34565689 | ||
| Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study | Q34605979 | ||
| Statins: a perspective for left ventricular hypertrophy treatment | Q34662787 | ||
| Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography | Q35582468 | ||
| Does physical activity lower blood pressure: a critical review of the clinical trials | Q36121726 | ||
| Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis | Q36830610 | ||
| Renal nerves in the maintenance of hypertension: a potential therapeutic target. | Q37738022 | ||
| Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy | Q38260701 | ||
| Diagnosis and Treatment of Systolic Heart Failure in the Elderly | Q39417629 | ||
| Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method | Q39802766 | ||
| The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy | Q40380047 | ||
| Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists | Q40380059 | ||
| Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis. | Q40380089 | ||
| Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy | Q40599706 | ||
| Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies | Q40982204 | ||
| Cardiac hypertrophy and failure in hypertension | Q41067687 | ||
| Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy | Q41123026 | ||
| Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. | Q41230771 | ||
| Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension | Q41943327 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy | Q43088579 | ||
| Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy | Q43225799 | ||
| Renal sympathetic-nerve ablation for uncontrolled hypertension | Q43285253 | ||
| Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial | Q43610373 | ||
| Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril | Q43753467 | ||
| The progression from hypertension to congestive heart failure | Q43812016 | ||
| Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation | Q44179202 | ||
| Association between cardiovascular outcomes and antihypertensive drug treatment in older women | Q44488856 | ||
| Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy | Q44687063 | ||
| Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. | Q45145783 | ||
| Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events | Q45152747 | ||
| Prognostic significance of left ventricular mass change during treatment of hypertension | Q45152749 | ||
| Diuretic therapy for hypertension and the risk of primary cardiac arrest | Q45285350 | ||
| Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents | Q45335327 | ||
| Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy | Q46157336 | ||
| Role of oxidative stress in transition of hypertrophy to heart failure | Q46265393 | ||
| Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement | Q46307976 | ||
| Left ventricular changes in isolated office hypertension: a blood pressure-matched comparison with normotension and sustained hypertension. | Q48518152 | ||
| Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea | Q48640268 | ||
| Left ventricular mass reduction during salt depletion in arterial hypertension | Q72830397 | ||
| Hypertensive heart disease syndrome in women in a cardiology practice | Q73666178 | ||
| Left ventricular hypertrophy in athletes | Q73919653 | ||
| Carvedilol prevents severe hypertensive cardiomyopathy and remodeling | Q74777449 | ||
| Left ventricular hypertrophy in patients with renal artery stenosis | Q79434699 | ||
| Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study | Q80704313 | ||
| Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients | Q80761665 | ||
| Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients | Q81038774 | ||
| Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate | Q84399115 | ||
| Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy | Q84517546 | ||
| Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. | Q50614527 | ||
| Physiologic left ventricular cavity dilatation in elite athletes. | Q50847643 | ||
| Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. | Q50959968 | ||
| Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval. | Q50963797 | ||
| Electrophysiological effects of magnesium on cells in the canine sinus node and false tendon | Q52703456 | ||
| Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. | Q52708506 | ||
| Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. | Q52901466 | ||
| Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study) | Q57073374 | ||
| Left ventricular hypertrophy has a greater impact on survival in women than in men | Q57154508 | ||
| Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study | Q57740701 | ||
| Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men | Q70006383 | ||
| Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment | Q70965048 | ||
| 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X | Q71776398 | ||
| Comparison of target organ damage in renovascular and essential hypertension | Q71808445 | ||
| ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption | Q71971777 | ||
| Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischemia, and microvascular angina | Q72157121 | ||
| Decreased adrenergic response in hypertensive patients without left ventricular hypertrophy | Q72374081 | ||
| Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS) | Q72425701 | ||
| Prevalence and natural history of electrocardiographic left ventricular hypertrophy | Q72796161 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| risk factor | Q1475848 | ||
| left ventricular hypertrophy | Q1628627 | ||
| hypertension | Q95566669 | ||
| P304 | page(s) | 495349 | |
| P577 | publication date | 2011-06-30 | |
| P1433 | published in | International Journal of Hypertension | Q24031588 |
| P1476 | title | Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications | |
| P478 | volume | 2011 |
| Q36460444 | AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy |
| Q55455553 | Aging-Induced Biological Changes and Cardiovascular Diseases. |
| Q28580953 | Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts |
| Q47843508 | Antiapoptotic effect of exercise training on ovariectomized rat hearts |
| Q48655758 | Antihypertensive Therapies and Left Ventricular Hypertrophy |
| Q40823003 | Association between high-sensitivity troponin T, left ventricular hypertrophy, and myocardial performance index |
| Q40742852 | Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population |
| Q57475996 | Association of histamine with hypertension-induced cardiac remodeling and reduction of hypertrophy with the histamine-2-receptor antagonist famotidine compared with the beta-blocker metoprolol |
| Q38199667 | Atrial natriuretic factor receptor guanylate cyclase, ANF-RGC, transduces two independent signals, ANF and Ca(2+). |
| Q46240569 | Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction |
| Q48099080 | Blunting of estrogen modulation of cardiac cellular chymase/RAS activity and function in SHR. |
| Q39019089 | Cardiac inositol 1,4,5-trisphosphate receptors |
| Q38678302 | Cardiac telomere length in heart development, function, and disease |
| Q58697573 | Cardiometabolic Changes in Different Gonadal Female States Caused by Mild Hyperuricemia and Exposure to a High-Fructose Diet |
| Q97536258 | Carvacrol Ameliorates Pathological Cardiac Hypertrophy in Both In-vivo and In-vitro Models |
| Q60686102 | Combined effects of 17β-estradiol and exercise training on cardiac apoptosis in ovariectomized rats |
| Q93053227 | Correlation between adolescent chronic emotional stress and incidence of adult cardiovascular disease in female rats |
| Q33590761 | Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administration |
| Q37219607 | ECG low QRS voltage and wide QRS complex predictive of centenarian 360-day mortality |
| Q92946217 | Echocardiographic Changes in Newly Diagnosed Type 2 Diabetes Mellitus Patients with and without Hypertension |
| Q38376700 | Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). |
| Q36567713 | Effects of occupational exposure to lead on left ventricular echocardio graphic variables |
| Q41592049 | Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias. |
| Q90179509 | Environmental and Health Impacts of Air Pollution: A Review |
| Q41440623 | Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction. |
| Q52945637 | Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography. |
| Q92549343 | IMPACT OF BLOOD PRESSURE COMPONENTS ON LEFT VENTRICULAR HYPERTROPHY REMODELING |
| Q37432845 | Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study. |
| Q37447697 | Involvement of microRNA-133 and -29 in cardiac disturbances in diabetic ovariectomized rats |
| Q37510643 | Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors |
| Q39155857 | Left ventricular hypertrophy in athletes and hypertensive patients |
| Q92671897 | Left ventricular mass index and subendocardial myocardial function in children with chronic kidney disease, a transmural strain and three-dimensional echocardiographic study |
| Q100433652 | Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study |
| Q89682859 | Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma |
| Q37380847 | Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. |
| Q37090170 | Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling |
| Q34808068 | Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy |
| Q58091796 | Pathological cardiac remodeling occurs early in CKD mice from unilateral urinary obstruction, and is attenuated by Enalapril |
| Q36975973 | Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria |
| Q44644755 | Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats |
| Q87980794 | Role of Cardiovascular Ultrasound in the Evaluation of Obese Subjects |
| Q91143412 | Silencing of the Na+/H+ exchanger 1(NHE-1) prevents cardiac structural and functional remodeling induced by angiotensin II |
| Q47382088 | Subclinical ventricular repolarization abnormality in uncontrolled compared with controlled treated hypertension. |
| Q41573480 | Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms |
| Q87980984 | The Association of Left Ventricular Mass Index with Metabolic Syndrome in Comparison to Hypertensive Patients |
| Q37534674 | The Coexistence of Hypertension and Ovariectomy Additively Increases Cardiac Apoptosis |
| Q92856857 | The Potential Role of Circulating Endothelial Cells and Endothelial Progenitor Cells in the Prediction of Left Ventricular Hypertrophy in Hypertensive Patients |
| Q41048467 | The utility of copy number variation (CNV) in studies of hypertension-related left ventricular hypertrophy (LVH): rationale, potential and challenges |
| Q37009873 | Trends in the treatment of hypertension from the perspective of traditional chinese medicine |
| Q26798060 | Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice |
| Q38253994 | Vitamin D: recent advances and implications for athletes. |
| Q52721044 | XRCC3 polymorphism is associated with hypertension-induced left ventricular hypertrophy. |
Search more.